Meeting
Abstract Number: 129
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Over 6 million people in the US have a diagnosis of atrial fibrillation. Given the increased risk for stroke and systemic embolism, many patients are treated with direct oral anticoagulants (DOACs) to reduce their risk. In the major trials comparing to DOACs to warfarin for stroke and systemic embolism prevention in atrial fibrillation, DOACs […]
Abstract Number: 494
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 68-year-old man presented with dyspnea, wheezing and productive cough. He was hypoxemic and a chest radiograph revealed a left lower lobe infiltrate and he was admitted with a Chronic Obstructive Pulmonary Disease exacerbation and pneumonia. His troponin was mildly elevated and he was started on a heparin infusion. The intravenous line infusing […]
Abstract Number: 836
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Case Presentation: A 90-year-old Caucasian female with non-valvular atrial fibrillation, on therapeutic anticoagulation with warfarin was admitted with community acquired pneumonia. She was treated with Levofloxacin. She underwent cardioversion for symptomatic atrial fibrillation with rapid ventricular rate and was later switched to Rivaroxaban 20 mg. Hepatic and renal function were within normal limits (creatinine clearance […]